5395242026-07-245395242026-07-242026-07-245395242026-07-24in-capmkt:FinancialYear1Member5395242026-07-24in-capmkt:FinancialYear2Member5395242026-07-24in-capmkt:FinancialYear3Member5395242026-07-242026-07-24in-capmkt:FinancialYear1Member5395242026-07-242026-07-24in-capmkt:FinancialYear2Member5395242026-07-242026-07-24in-capmkt:FinancialYear3Memberiso4217:INRxbrli:pure539524Dr. Lal Path Labs Ltd.LALPATHLABNOTLISTEDINE600L01024NewAcquisition (including agreement to acquire)true2026-07-2413:30:002026-07-24The Board of Directors of the Company took note that the Board of Dr. Lal Ventures Private Limited, Wholly Owned Subsidiary of the Company, approved acquisition of stake in Neuome Technologies Private Limited (“Neuome”).Dr. Lal Ventures Private LimitedSubsidiaryNeuome Technologies Private Limited6000000-110000009000000falsefalsetrueManufacturing/ developing Chemical Products and innovative Solutions useful in sample preservation, pre-analytical technologies and bio-banking business for Diagnostic/ HealthcareTo gain access to Neuome’s innovative sample preservation and biobanking solutions.NAtrue31-08-2026Cash35000000The proposed investment will be upto INR 35 Mn. for subscription of 30% stake.3500000000.3Neuome was incorporated on April 16, 2020, under the laws of India and is engaged in business of manufacturing/ developing Chemical Products and innovative Solutions2025-202660000002024-202510000002023-202444000000INDIAThe aforementioned acquisition does not qualify as a related party transaction. However, due to limitations in the XBRL format, the question, Whether the transaction was conducted at arm's length, provides only a Yes/No dropdown option. We selected Yes; however, this should be interpreted as Not Applicable.